Chajec, Don-Siemion & Zyto has advised the NanoGroup S.A. biotech company on preliminary stages of the process of listing the company on the Warsaw Stock Exchange.
The first stage, CDZ reports, involved development of the holding group’s concept and the creation of the documentation necessary to create the holding’s structure. The firm also assisted with the second stage, which involved the development of the legal component of the prospectus that was approved by the Polish Financial Supervision Authority on October 13, 2017.
According to CDZ, "NanoGroup S.A. has three subsidiaries (NanoVelos S.A., NanoSanguis S.A. and NanoThea S.A.) involved in the development of five advanced biotechnological projects."
“The public offering is designed to raise additional funds to finance biotechnological projects currently developed by NanoGroup S.A. and connected with the treatment and prevention of oncological diseases, transplantology and blood donation," said Marek Borzestowski, President of NanoGroup S.A. "The offering is also intended to finance investment in new projects."
The CDZ legal team is headed by Partner Maciej Kotlicki and lawyer Piotr Rychta, assisted by lawyers Malgorzata Sas-Madej, Aleksandra Hulewicz, Monika Ciechomska, and Marcin Lizurek.